CIK 0001497253
- Non-accelerated filer
- Smaller reporting company
VivoSim Labs, INC.
Sign in to watch- Ticker
- VIVS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 271488943
- Phone
- +1 858-224-1000
- Business address
- 11555 SORRENTO VALLEY ROAD, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- ORGANOVO HOLDINGS, INC., REAL ESTATE RESTORATION & RENTAL, INC.
- Open-market buys, last 90 days
- $2,804
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$2,804. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-02-13 | MICHAELS BARRY D Chief Financial Officer | Exercise or conversion | +22,000 | $2.25 | $50K | 572,432 |
| 2014-02-13 | MICHAELS BARRY D Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −22,000 | 40,500 | ||
| 2014-02-13 | Murphy Keith Chairman, CEO and President | Shares withheld for taxes | −27,105 | $9.92 | $269K | 6,074,643 |
| 2014-02-13 | Murphy Keith Chairman, CEO and President | Grant or award · Stock Option (Right to Buy) | +27,105 | 27,105 | ||
| 2014-01-29 | Renard Michael EVP of Commercial Operations | Exercise or conversion | +30,000 | $1.65 | $50K | 30,000 |
| 2014-01-29 | Renard Michael EVP of Commercial Operations | Sale | −30,000 | $9.93 | $298K | 0 |
| 2014-01-29 | Renard Michael EVP of Commercial Operations | Exercise or conversion · Stock Option (Right to Buy) | −30,000 | 560,000 | ||
| 2014-01-27 | Renard Michael EVP of Commercial Operations | Exercise or conversion | +10,000 | $1.65 | $17K | 10,000 |
| 2014-01-27 | Renard Michael EVP of Commercial Operations | Sale | −10,000 | $8.92 | $89K | 0 |
| 2014-01-27 | Renard Michael EVP of Commercial Operations | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 590,000 | ||
| 2014-01-21 | Murphy Keith Chairman, CEO and President | Sale | −100,000 | $10.86 | $1.1M | 6,101,748 |
| 2013-12-20 | MICHAELS BARRY D Chief Financial Officer | Exercise or conversion | +47,619 | $2.10 | $100K | 550,432 |
| 2013-12-20 | MICHAELS BARRY D Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −47,619 | 32,068 | ||
| 2013-12-16 | MICHAELS BARRY D Chief Financial Officer | Sale | −85,353 | $9.07 | $774K | 502,813 |
| 2013-12-10 | Murphy Keith Chairman, CEO and President | Sale | −100,000 | $10.08 | $1.0M | 6,201,748 |
| 2013-11-13 | Murphy Keith Chairman, CEO and President | Sale | −100,000 | $9.64 | $964K | 6,301,748 |
| 2013-11-13 | David Eric Chief Strategy Officer | Sale | −16,470 | $10.39 | $171K | 731,306 |
| 2013-10-18 | Murphy Keith Chairman, CEO and President | Sale | −30,000 | $6.63 | $199K | 6,401,748 |
| 2013-10-16 | Murphy Keith Chairman, CEO and President | Sale | −70,000 | $5.76 | $403K | 6,431,748 |
| 2013-10-10 | David Eric Chief Strategy Officer | Option exercise | +20,000 | $1.00 | $20K | 751,306 |
Page 15 of 18 · 356 trades